Eisai completes rolling submission to US FDA for LEQEMBI IQLIK supplemental biologics license application Read more
CPHI & PMEC India unites over 50,000 professionals and global leaders to shape the future of pharma industry Read more
Zydus, RK Pharma enters into an exclusive licensing and commercialisation agreement for a novel 505(b)(2) oncology product for USA market Read more
India well-positioned to evolve as an innovation-led pharma nation over next 5 Years: CDSCO Read more